Rheumatoid arthritis (RA) is a chronic and systemic inflammatory disease affecting 0.5–1%
of the population worldwide. Interstitial lung disease (ILD) is a serious pulmonary …

Idiopathic inflammatory myopathies (IIMs) are heterogeneous disorders that affect the
skeletal muscles. Polymyositis, dermatomyositis, and inclusion body myositis are major IIM …

The idiopathic inflammatory myopathies (IIMs) are a diverse group of connective tissue
diseases characterized by varying degrees of muscle inflammation and systemic …

Although interstitial lung disease (ILD) is a leading cause of morbidity and mortality in
patients with inflammatory myopathies, the current definition and diagnostic criteria of …

Idiopathic inflammatory myopathies, including polymyositis (PM), dermatomyositis (DM), and
clinically amyopathic DM (CADM), are a diverse group of autoimmune diseases …

Objective The efficacy of tofacitinib (TOF) in the early diagnosis of melanoma differentiation–
associated gene 5 (MDA5)–related interstitial lung disease (ILD) has been described …

Inflammatory myopathies (IM) are auto-immune connective tissue diseases characterized by
muscle involvement and by extramuscular manifestations. As such, pulmonary …

Interstitial lung disease (ILD) frequently complicates the inflammatory myopathies and at
times is the most prominent clinical feature. Over the years, there has been a growing …

Interstitial lung disease (ILD) is one of the most serious pulmonary complications of
connective tissue diseases (CTDs) and it is characterized by a deep impact on morbidity and …

Background and objective The efficacy of combination therapy with corticosteroids and CNI,
TAC and CsA, for PM/DM‐ILD has been described retrospectively. However, it remains …